Empower Clinics Inc.
EPWCF · OTC
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $2 | $2 | $1 |
| % Growth | -72.8% | 1.3% | 40.4% | – |
| Cost of Goods Sold | $0 | $1 | $1 | $1 |
| Gross Profit | $0 | $1 | $1 | $0 |
| % Margin | 4% | 59.2% | 47.3% | 21.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $1 | $1 | $1 |
| SG&A Expenses | $1 | $2 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $2 | $2 | $2 |
| Operating Income | -$1 | -$1 | -$1 | -$2 |
| % Margin | -279.6% | -57.6% | -79.6% | -146% |
| Other Income/Exp. Net | -$1 | $0 | $3 | -$1 |
| Pre-Tax Income | -$2 | -$0 | $2 | -$2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2 | -$0 | $2 | -$2 |
| % Margin | -555.4% | -29% | 139.4% | -195.6% |
| EPS | -0.033 | -0.007 | 0.016 | -0.006 |
| % Growth | -397% | -141.8% | 350.8% | – |
| EPS Diluted | -0.033 | -0.007 | 0.011 | -0.011 |
| Weighted Avg Shares Out | 72 | 349 | 70 | 345 |
| Weighted Avg Shares Out Dil | 72 | 349 | 207 | 207 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $1 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$0 | $2 | -$2 |
| % Margin | -269.3% | -8.4% | 158.7% | -190.6% |